These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35051706)

  • 1. Click inspired novel pyrazole-triazole-persulfonimide & pyrazole-triazole-aryl derivatives; Design, synthesis, DPP-4 inhibitor with potential anti-diabetic agents.
    Nidhar M; Khanam S; Sonker P; Gupta P; Mahapatra A; Patil S; Yadav BK; Singh RK; Kumar Tewari A
    Bioorg Chem; 2022 Mar; 120():105586. PubMed ID: 35051706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of triazole-based uracil derivatives bearing amide moieties as novel dipeptidyl peptidase-IV inhibitors.
    Deng X; Han L; Zhou J; Zhang H; Li Q
    Bioorg Chem; 2017 Dec; 75():357-367. PubMed ID: 29096096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and anti-diabetic activity of triazolotriazine derivatives as dipeptidyl peptidase-4 (DPP-4) inhibitors.
    Patel BD; Bhadada SV; Ghate MD
    Bioorg Chem; 2017 Jun; 72():345-358. PubMed ID: 28302310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lead modification via computational studies: Synthesis of pyrazole-containing β-amino carbonyls for the treatment of type 2 diabetes.
    Nidhar M; Kumar V; Mahapatra A; Gupta P; Yadav P; Sonker P; Kumar A; Mishra S; Singh RK; Tewari AK
    Chem Biol Drug Des; 2023 Mar; 101(3):638-649. PubMed ID: 36271321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surrogating and redirection of pyrazolo[1,5-a]pyrimidin-7(4H)-one core, a novel class of potent and selective DPP-4 inhibitors.
    Deng X; Shen J; Zhu H; Xiao J; Sun R; Xie F; Lam C; Wang J; Qiao Y; Tavallaie MS; Hu Y; Du Y; Li J; Fu L; Jiang F
    Bioorg Med Chem; 2018 Feb; 26(4):903-912. PubMed ID: 29373269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of triazole based uracil derivatives as novel DPP-4 inhibitors.
    Li Q; Han L; Zhang B; Zhou J; Zhang H
    Org Biomol Chem; 2016 Oct; 14(40):9598-9611. PubMed ID: 27714283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational design and synthesis of new tetralin-sulfonamide derivatives as potent anti-diabetics and DPP-4 inhibitors: 2D & 3D QSAR, in vivo radiolabeling and bio distribution studies.
    Abd El-Karim SS; Anwar MM; Syam YM; Nael MA; Ali HF; Motaleb MA
    Bioorg Chem; 2018 Dec; 81():481-493. PubMed ID: 30243239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, nitric oxide release, and dipeptidyl peptidase-4 inhibition of sitagliptin derivatives as new multifunctional antidiabetic agents.
    Xie Y; Shao L; Wang Q; Bai Y; Chen Z; Li N; Xu Y; Li Y; Yang G; Bian X
    Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3731-3735. PubMed ID: 30343953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and biological evaluation of glycolamide, glycinamide, and β-amino carbonyl 1,2,4-triazole derivatives as DPP-4 inhibitors.
    Fuh MT; Tseng CC; Li SM; Tsai SE; Chuang TJ; Lu CH; Yang YC; Tsai HJ; Wong FF
    Bioorg Chem; 2021 Sep; 114():105049. PubMed ID: 34147879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and biological evaluation of novel pyrimidinedione derivatives as DPP-4 inhibitors.
    Li N; Wang LJ; Jiang B; Guo SJ; Li XQ; Chen XC; Luo J; Li C; Wang Y; Shi DY
    Bioorg Med Chem Lett; 2018 Jul; 28(12):2131-2135. PubMed ID: 29773502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dipeptidyl peptidase IV Inhibitory activity of Terminalia arjuna attributes to its cardioprotective effects in experimental diabetes: In silico, in vitro and in vivo analyses.
    Mohanty IR; Borde M; Kumar C S; Maheshwari U
    Phytomedicine; 2019 Apr; 57():158-165. PubMed ID: 30668318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, evaluation and molecular docking of thiazolopyrimidine derivatives as dipeptidyl peptidase IV inhibitors.
    Sharma M; Gupta M; Singh D; Kumar M; Kaur P
    Chem Biol Drug Des; 2012 Dec; 80(6):918-28. PubMed ID: 22943413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of Novel DPP-IV Inhibitors as Potential Candidates for the Treatment of Type 2
    Musoev A; Numonov S; You Z; Gao H
    Molecules; 2019 Aug; 24(16):. PubMed ID: 31394858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, in vitro evaluation, and computational simulations studies of 1,2,3-triazole analogues as DPP-4 inhibitors.
    Vo DV; Hong KH; Lee J; Park H
    Bioorg Med Chem; 2021 Jan; 29():115861. PubMed ID: 33214038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyrano[2,3-c]pyrazole fused spirooxindole-linked 1,2,3-triazoles as antioxidant agents: Exploring their utility in the development of antidiabetic drugs via inhibition of α-amylase and DPP4 activity.
    Chahal S; Rani P; Shweta ; Goel KK; Joshi G; Singh R; Kumar P; Singh D; Sindhu J
    Bioorg Chem; 2024 Jun; 147():107363. PubMed ID: 38657527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DPP-IV Inhibitory Phenanthridines: Ligand, Structure-Based Design and Synthesis.
    Khalaf RA; Masalha D; Sabbah D
    Curr Comput Aided Drug Des; 2020; 16(3):295-307. PubMed ID: 30526469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and Discovery of Novel 1,3,5-Triazines as Dipeptidyl Peptidase-4 Inhibitor against Diabetes.
    Wang Y; Tang X; Yi L
    Pharmacology; 2019; 103(5-6):273-281. PubMed ID: 30799431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural optimization of pyrazolo[1,5-a]pyrimidine derivatives as potent and highly selective DPP-4 inhibitors.
    Shen J; Deng X; Sun R; Tavallaie MS; Wang J; Cai Q; Lam C; Lei S; Fu L; Jiang F
    Eur J Med Chem; 2020 Dec; 208():112850. PubMed ID: 32987315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of the benzamide fragment targeting the S
    Deng X; Wang N; Meng L; Zhou S; Huang J; Xing J; He L; Jiang W; Li Q
    Bioorg Chem; 2020 Jan; 94():103366. PubMed ID: 31640932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of novel xanthine compounds targeting DPP-IV and GPR119 as anti-diabetic agents.
    Li G; Huan Y; Yuan B; Wang J; Jiang Q; Lin Z; Shen Z; Huang H
    Eur J Med Chem; 2016 Nov; 124():103-116. PubMed ID: 27560285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.